Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry
Background Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real‐world patients with acute coronary syndromes treated with percutaneous coronary intervention (PCI) remain unclear. We sought to examine whether treatment with ti...
Main Authors: | Sebastian Völz, Petur Petursson, Jacob Odenstedt, Dan Ioanes, Inger Haraldsson, Oskar Angerås, Christian Dworeck, Geir Hirlekar, Anna Myredal, Per Albertsson, Truls Råmunddal, Björn Redfors, Elmir Omerovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.119.015990 |
Similar Items
-
Ischemic ST‐Segment Depression Maximal in V1–V4 (Versus V5–V6) of Any Amplitude Is Specific for Occlusion Myocardial Infarction (Versus Nonocclusive Ischemia)
by: H. Pendell Meyers, et al.
Published: (2021-12-01) -
Association between clinical parameters and ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
by: Ramūnas Unikas, et al.
Published: (2016-01-01) -
Electrocardiographic signs of the left main coronary artery disease in acute coronary syndrome
by: E. S. Eniseeva, et al.
Published: (2020-12-01) -
ECG patterns suggestive of high-risk coronary anatomy in non-ST-segment elevation acute coronary syndrome – an analysis of real-world patients
by: Natalia Gołąbek, et al.
Published: (2023-10-01) -
Effect of COVID-19 Pandemic on Acute Coronary Syndrome Clinical Practice Patterns: Findings from a Multicenter Clinician Survey in China
by: Feng Hu, et al.
Published: (2022-10-01)